IL13 promoter polymorphism -1112C/T modulates the adverse effect of tobacco smoking on lung function

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 8, 2007, Pages 748-752

  Sadeghnejad, Alireza ^a   Meyers, Deborah A ^a   Bottai, Matteo ^b   Sterling, David A ^c   Bleecker, Eugene R ^a   Ohar, Jill A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Gene environment interaction; Interleukin 13; Polymorphism; Tobacco smoke

Indexed keywords

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTERLEUKIN 13 GENE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-13; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SMOKING; VITAL CAPACITY;

EID: 35348968302     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200704-543OC     Document Type: Article

References (22)

1. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61:935-939.
2. Rodriguez F, de la Roza C, Jardi R, Schaper M, Vidal R, Miravitlles M. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD. Chest 2005;127:1537-1543.
3. Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT, Meyers DA, Postma DS, Bleecker ER. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001;25:377-384.
4. Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, Bleecker ER. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002;70:230-236.
5. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, von Mutius E. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006;117:269-274.
6. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, van der Zee JS, Dentener MA, Wouters EF, Verweij CL. Chronic obstructive pulmonary disease is associated with the 21055 IL-13 promoter polymorphism. Genes Immun 2002;3:436-439.
7. Hegab AE, Sakamoto T, Saitoh W, Massoud HH, Massoud HM, Hassanein KM, Sekizawa K. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 2004;126:1832-1839.
8. He B, Zhao MW, Ning LD, Jiang L, Yao WZ. The study of interleukin-13 gene promoter polymorphism in patients with chronic obstructive pulmonary disease [Chinese]. Zhonghua Jie He He Hu Xi Za Zhi 2004; 27:529-532.
9. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
10. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000;106:1081-1093.
11. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005;115:747-754.
12. van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, Stapel SO, Bakker A, Verweij CL, Aarden LA, van der Zee JS. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999;1:61-65.
13. Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, et al. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol 2006;177:8633-8642.
14. Sadeghnejad A, Meyers A, Ohar J, Bleecker E. IL13 promoter polymorphism enhances the adverse effect of smoking on lung function [abstract]. Am J Respir Crit Care Med 2007;175:A563.
15. Ohar J, Sterling DA, Bleecker E, Donohue J. Changing patterns in asbestos-induced lung disease. Chest 2004;125:744-753.
16. International Labour Office. ILO international classification of radiographs of pneumoconiosis: occupational safety and health series, no. 22, revised 1980. Geneva, Switzerland; International Labour Office; 1980.
17. American Thoracic Society. Standardization of spirometry: update 1995. Am J Respir Crit Care Med 1994;152:1107-1136.
18. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-664.
19. Tarazona-Santos E, Tishkoff SA. Divergent patterns of linkage disequilibrium and haplotype structure across global populations at the interleukin-13 (IL13) locus. Genes Immun 2005;6:53-65.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21: 263-265.
21. Hill WG, Robertson A. The effect of linkage on limits to artificial selection. Genet Res 1966;8:269-294.
22. Koenker R. Quantile regression. New York; Cambridge Press; 2005.